Customized Operational Support for Rural Hospitals
At Blue & Co., our mission is centered around serving the whole client. We understand that true success for an organization extends beyond the numbers and financial metrics. That’s why we founded Alliant Management – to provide our rural hospitals with a holistic approach to management services beyond our traditional consulting.
Alliant Management provides customized business solutions for rural hospital systems that are owned and operated by county, city, private NFP, and private for profit facilities. We primarily serve Critical Access, Free-standing, and Multi-Hospital Systems with populations ranging from 10,000 to 70,000.
Some of our services include:
- Merger & acquisition strategies
- Benchmarking reports
- Annual training & strategic planning
- Operations assessments
- C-suite placement, mentoring, and reviews
- Accreditation & licensure preparation
- General financial reporting
- Source supply chain volume discounts
- Cost reporting optimization
- Medicare Bad Debt recoveries
- 340B optimization
- … and much more
Connect with our team.
To learn more about our services and areas of expertise, send us a message.
The new Medicare Bad Debt template (Exhibit 2A) and S-10 template (Exhibit 3B and 3C) have been finalized by Medicare and are now required for cost reporting periods ending on or after September 30, 2023. This deadline is quickly approaching, and Blue & Co. wants to be sure you are prepared. If you are feeling […]
CARMEL, Ind. (July 25, 2023) – Blue & Co., LLC is proud to announce that Jeff Moffatt, CPA/ABV/CITP, ASA, CVA, FACHE, recently received the fellowship designation from the Healthcare Financial Management Association (HFMA). “I am extremely honored to be recognized as a fellow of the HFMA,” said Moffatt, a senior manager at Blue. “I would […]
On Friday July 7th, 2023, CMS released a proposed rule outlining a plan to correct and reverse the 340B payment cuts from calendar years (CY) 2018 through 2022. This proposed rule is in response to last years Supreme Court ruling that CMS lacked authority to reduce reimbursement for drugs to average sale price (ASP) minus […]